The size of the global preclinical in-vivo imaging market is forecasted to grow at a CAGR of 5.76% from 2022 to 2027. The size of the market is predicted to value USD 999.3 million by 2027 from USD 755.31 million in 2022.
Preclinical imaging is the visualization of living animals for research purposes, such as drug development. Imaging modalities are crucial for researchers to observe changes, either at the organ, tissue, cell, or molecular level, responding to physiological or environmental changes. Non-invasive imaging modalities and in-vivo are essential to study animal models longitudinally. Techniques such as high-frequency micro-ultrasound, magnetic resonance imaging (MRI), and computed tomography (CT) are usually used for anatomical imaging. In contrast, optical imaging (fluorescence and bioluminescence), positron emission tomography (PET), and single-photon emission computed tomography (SPECT) are usually used for molecular visualizations. The preclinical in-vivo imaging industry has experienced myriad technological advancements, market changes due to industry consolidation, and growth in government funding and support for research studies across the globe over the past decade.
Globally, factors such as technological advancements in molecular imaging modalities, growing acceptance of preclinical imaging as a legitimate drug development tool are fuelling the demand for preclinical imaging systems and reagents.
Declining NIH budgets for medical science research studies and the high implementation cost of sophisticated preclinical imaging systems restrict the growth of the global preclinical imaging market.
REPORT COVERAGE:
REPORT METRIC |
DETAILS |
Market Size Available |
2021 to 2027 |
Base Year |
2021 |
Forecast Period |
2022 to 2027 |
Segments Covered |
By Modality, Reagent & Region |
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
Regions Covered |
North America, Europe, APAC, Latin America, Middle East & Africa |
Market Leaders Profiled |
Aspect Imaging, Biospace Lab S.A., Bruker Corporation, LI-COR Biosciences, Mediso Ltd., MILabs B.V., MR Solutions Ltd, PerkinElmer, Inc., TriFoil Imaging and FUJIFILM VisualSonics, Inc. |
This research report on the global preclinical in-vivo imaging market has been segmented and sub-segmented based on the modality, reagent, and region.
Preclinical In-vivo Imaging Market - By Modality:
Based on modality, the segment of Micro-ultrasound is anticipated to grow with the fastest CAGR. It would be a significant contributor to the global market for preclinical In-vivo imaging. Micro-ultrasound is a smaller ultrasound version with a wider variety of applications, particularly in small animal model research. Some smaller versions of imaging methods improve the techniques ' efficacy. These often decrease the number of animals required for a specific study.
Preclinical In-vivo Imaging Market - By Reagent:
Based on the reagent, the Ultrasound Contrast agents segment is anticipated to dominate the global market owing to their increased application in multiple imaging methods.
Preclinical In-vivo Imaging Market – By Region:
Regionally, North America holds the largest share of the global preclinical imaging market, followed by Europe. North America dominates the global market given the rapid adoption by end-users of several types of modalities, technological advancement, increased prevalence of chronic diseases like cancer, cardiovascular disease, and many others.
Factors including rising R&D activities by big pharma and biotech companies in developing nations and increased government funding for the pharmaceutical industry's development are stimulating the growth of the preclinical imaging market in the Asia-Pacific region.
KEY MARKET PLAYERS:
Companies like Aspect Imaging, Biospace Lab S.A., Bruker Corporation, LI-COR Biosciences, Mediso Ltd., MILabs B.V., MR Solutions Ltd, PerkinElmer, Inc., TriFoil Imaging, and FUJIFILM VisualSonics, Inc. are currently playing a leading role in the global preclinical in-vivo imaging market.
RECENT MARKET HAPPENINGS:
THIS REPORT COMES WITH:
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: sales@marketdataforecast.com